Pipeline
R&D
About
About neuramedy
Company identity
History
Vision&Goal
R&D
Pipeline
People
Members
Partnership
Investors
News&Notice
News&Notice
Contact us
Contact us
Pipeline
Class
Target
Pipeline
Indication/
Application
Discovery (Hit/lead/candidate)
Pre clinical
clinical
Antibodies
(Tomaralimab)
TLR2
NM-101
NM-102
PD/AD
Antibodies
(Novel)
TLR2
NM-201
NM-202
BBB penetrating antibody
BBB
NM-301
Brain delivery
Small molecule
αSyn aggregate
NM-401
NM-402
NM-403
PD
MSA
DLB
Diagnosis
αSyn aggregate
NM-501
PD
Neuramedy Co.,Ltd
Room 301, NaRin Building, 215-6, Yulgok-ro, Jongno-gu, Seoul, 03100, South Korea
Tel : +82-2-765-3344 | E-mail : contact@neuramedy.com
COPYRIGHT © Neuramedy Co.,Ltd ALL RIGHT RESERVED